Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity.
about
Vaccine adjuvants as potential cancer immunotherapeuticsA Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Expression and Function of TLR2 on CD4 Versus CD8 T Cells.Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cellsEducating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide.When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function.NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells.Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine.Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.Effects of Toll-like receptor signals in T-cell neoplasms.Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy.HIV-specific CD8⁺ T cells and HIV eradicationLung CD8+ T cells in COPD have increased expression of bacterial TLRs.TLR agonists: our best frenemy in cancer immunotherapyProtein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvantThe adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses.Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.Biological Response Modifier in Cancer Immunotherapy.Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.Use of adjuvants for immunotherapy.T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45RbHi T cells.The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses.A "Toll" for Th17 cell expansion.Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion.Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
P2860
Q26752522-E8BE66F3-0CC7-4093-99ED-00868D0EAE64Q30385378-D6655978-06E7-4374-8D22-EFC069C886A7Q33631927-54AD8E59-78B2-4C12-8FF5-8FA580947353Q34149109-1F77FA1F-146F-4806-ABD1-33CDA5D4A62CQ34258820-820D0024-4342-4904-ACF9-6B29A5FD517AQ34310528-39194C35-7179-4EEC-BFFF-F3643A951D9FQ34359613-F0AD6A46-65DC-4395-8E3C-4DEE451D3AC2Q34677842-6E2FFEFA-4D81-4934-8EAB-9379552F8F12Q35008279-D6A53DA0-ECD2-43C4-B641-9E3B3B961D7AQ35183900-1183B8C0-C2A8-4DDB-9123-CE623FD0C54DQ35229659-F83C5D34-2753-4AD7-8094-CE30861025B6Q35606746-C3D720D6-7315-402D-A14E-0603DD59C97FQ35612358-4E92F92C-114C-4DB1-BDB5-6FA44726E215Q36293678-20D91687-93F0-4CCE-B9EE-A9342B21034DQ36293682-12FA4684-9B12-4D7F-9051-A492B68549C2Q36356744-F2B46234-760D-45DF-81C9-DCA9415FF1D8Q36456469-CDE3F048-6BBF-4459-930D-EED27F707ABAQ36515071-7F3388B7-DB34-4F53-9A4C-D0C74E2D705FQ36643067-44E10E9C-A823-49A7-AEA0-5529EAD4F5A7Q36850457-5D18FC48-75BA-44ED-A420-16B9FD169AB8Q37198471-2DB9DB44-4684-45C0-901D-CDF9420E760EQ37265478-98B3A791-C3D6-46E7-8537-8BD685236582Q37444593-92B19BC2-B1AE-4D89-A850-0CF7F051FBD1Q37727208-D4A12DD1-6138-436D-80E7-4D9DB21913C0Q38240851-7EA24750-D17A-459F-8BA0-24D59CF61D60Q38270733-7E126B70-F548-4FEB-9170-4B7039BB78E8Q38704340-867D2D4E-A043-4C6D-A758-B00F9AF9C2DAQ38848213-3E957946-D52B-4EF9-B100-809A4F19F1BBQ39706240-28B6E5A8-5F4B-4957-9BF7-2724B61FB21BQ40163884-9956EE09-771A-48FA-A563-3E63F4807156Q41939919-61A5AC56-5A3D-4A84-8166-1DC62CBDC562Q42244917-1A828056-E6F1-49AE-B187-8A7A5F36A119Q42742596-7BD5E23E-D7DC-47F2-A56B-9DEC06488920Q46971707-1149F4CE-627F-4808-8D53-4D7A6908C91AQ47553095-A0338239-23B6-433B-8BB0-A796611D83A7
P2860
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Engagement of Toll-like recept ...... d augments antitumor activity.
@en
type
label
Engagement of Toll-like recept ...... d augments antitumor activity.
@en
prefLabel
Engagement of Toll-like recept ...... d augments antitumor activity.
@en
P2093
P2860
P356
P1433
P1476
Engagement of Toll-like recept ...... d augments antitumor activity.
@en
P2093
Cruz Velasco-Gonzalez
Degui Geng
Eduardo Davila
Liqin Zheng
Luis Sanchez-Perez
Nicole Asprodites
P2860
P304
P356
10.1096/FJ.08-108274
P407
P577
2008-06-27T00:00:00Z